Drug Execs To Testify At House Oversight After Drug Pricing Probe

Drug industry executives are scheduled to testify on drug pricing practices over two days at a House Oversight Committee hearing next week, following an 18-month committee probe into price increases, executive compensation and patent strategies. Former Celgene Corporation CEO Mark Alles, Bristol Myers Squibb CEO Giovanni Caforio and Teva Pharmaceuticals CEO Kåre Schultz will testify Wednesday (Sept. 30). The following day, Amgen CEO Robert Bradway, Mallinckrodt Pharmaceuticals CEO Mark Trudeau and Novartis AG President Thomas Kendris are scheduled to appear...